Children's Cancer Institute Australia

Recent papers from Children's Cancer Institute Australia

1. Patient‐specific genomic measurable residual disease markers for monitoring acute myeloid leukaemia and myeloid malignancyBritish Journal of Haematology · 2026
2. Exploring health anxiety among healthcare professionals: a scoping review and exploratory quantitative summary of health anxiety findingsBMC Health Services Research · 2026
3. PSEN1 Expression Identifies a Developmentally Distinct Favourable‐Prognosis State in SHH α MedulloblastomaInternational Journal of Developmental Neuroscience · 2026
4. Mechanosensitive Stanniocalcin-1 Suppresses Pulmonary Artery Smooth Muscle Cell Proliferation and Attenuates Experimental Pulmonary HypertensionCirculation Research · 2026
5. Use of patient-reported outcome measures in Australian pediatric oncology practice and researchCancer Survivorship Research & Care · 2026
6. Advanced Materials for Biologics Delivery to Brain TumorsAdvanced Materials · 2026
7. Beyond Knowledge Transfer: Caregivers’ Evolving Medication Information Needs Across Paediatric Oncology TreatmentJournal of Clinical Nursing · 2026
8. Precisely Engineering Biomimetic Nanoparticles via Controlled Cell Membrane CoatingSmall · 2026
9. Chronic obstructive pulmonary disease and risk of incident cardiovascular disease, chronic kidney disease, and death: a systematic review and meta-analysisEClinicalMedicine · 2026
10. Tracking Health Related Quality of Life From Diagnosis to Follow‐Up Among Australian Children With Acute Lymphoblastic LeukaemiaPediatric Blood & Cancer · 2026
11. MYCN-driven metabolic remodelling of the tumour microenvironment in neuroblastoma: implications for stromal biology and CAF heterogeneityCancer and Metastasis Reviews · 2026
12. NAD Metabolism in Acute Myeloid Leukaemia: Biological Rationale and Therapeutic OpportunitiesNutrients · 2026
13. The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric CancersCancer Research · 2026
14. Interplay of Epigenetic Reprogramming, Mitochondrial Metabolism, and Dopamine Signalling Pathways Uncovers Metabolic Vulnerabilities in Diffuse Midline GliomaCancers · 2026
15. Correction: An unexpected role for caspase-2 in neuroblastomaCell Death and Disease · 2026
16. Do young people who have been treated for cancer identify as ‘survivors’? Adolescents and young adults’ preferences for cancer-related identities in survivorshipJournal of Cancer Survivorship · 2026
17. Family experiences of receiving treatment recommendations in a precision medicine trial for poor-prognosis childhood cancernpj Genomic Medicine · 2026
18. Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN StudyJCO Precision Oncology · 2026
19. Preclinical evaluation of the ROR1‐targeting antibody–drug conjugates zilovertamab vedotin and VLS‐211 against B‐cell ALL patient‐derived xenograftsHemaSphere · 2026
20. ID #107 Family experiences of precision-guided treatment recommendations for poor prognosis paediatric Central Nervous System (CNS) cancerNeuro-Oncology Pediatrics · 2026